(Figures in the brackets refer to the same period the previous year)
During the third quarter of 2022, BioGaia's sales have been positively impacted by increased demand, mainly in the
For the third quarter, sales are preliminarily estimated at
BioGaia publishes the interim report for quarter three on
Follow us:
Subscribe to BioGaia press releases here
LinkedIn here
Contacts:
Email: ako@biogaia.se
Phone: +46 (0) 735 00 11 11
Email: mis@biogaia.se
Phone: +46 (0) 730 95 61 50
About BioGaia
BioGaia is an innovative Swedish healthcare company that develops, markets, and sells probiotic products with documented health benefits. The products are sold through local distribution partners in more than 100 countries worldwide. The class B share of the
This disclosure contains information that BioGaia is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person set out above, at
https://news.cision.com/biogaia/r/biogaia-s-results-for-the-third-quarter-to-exceed-market-expectations,c3648968
https://mb.cision.com/Main/3271/3648968/1639256.pdf
(c) 2022 Cision. All rights reserved., source